Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2024

Conditions
Obesity and Obesity-related Medical Conditions
Interventions
PROCEDURE

Laparoscopic sleeve gastrectomy

"Patients underwent SG, involving longitudinal resection of approximately 75% of the stomach along its greater curvature, with excision of the fundus and part of the body and antrum, preserving a portion of the latter and the pylorus itself. This results in a vertical tube-shaped gastric tube sleeve. After surgery, patients followed a free diet. Patients were evaluated at baseline and at 1, 3, 6, 9, and 12 months after starting the intervention."

OTHER

Obesity pharmacotherapy

Patients underwent 1 month of a very low calorie diet (VLCD) with 813 kcal/day, followed by a low calorie diet (LCD) for 11 months together with intensive physical exercise (30 min/day of brisk walking plus at least 3 h/week of aerobic exercise) with 2.4 mg/week of semaglutide (Ozempic®), given once weekly as subcutaneous injections. Patients were evaluated at baseline and at 1, 3, 6, 9 and 12 months after starting the interventions.

Trial Locations (2)

00135

IRCCS Catholic University of Rome, Rome

00161

Sapienza University of Rome, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER